209 related articles for article (PubMed ID: 23766903)
41. In vivo animal models of cerebral vasospasm: a review.
Megyesi JF; Vollrath B; Cook DA; Findlay JM
Neurosurgery; 2000 Feb; 46(2):448-60; discussion 460-1. PubMed ID: 10690735
[TBL] [Abstract][Full Text] [Related]
42. Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
Kiser TH
Hosp Pharm; 2013 Sep; 48(5 Suppl):S2-S9. PubMed ID: 35694374
[TBL] [Abstract][Full Text] [Related]
43. The Role of ABO Blood Group in Cerebral Vasospasm, Associated Intracranial Hemorrhage, and Delayed Cerebral Ischemia in 470 Patients with Subarachnoid Hemorrhage.
Dubinski D; Won SY; Konczalla J; Mersmann J; Geisen C; Herrmann E; Seifert V; Senft C
World Neurosurg; 2017 Jan; 97():532-537. PubMed ID: 27777156
[TBL] [Abstract][Full Text] [Related]
44. Hyperacute Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
Bar B; MacKenzie L; Hurst RW; Grant R; Weigele J; Bhalla PK; Kumar MA; Stiefel MF; Levine JM
Neurocrit Care; 2016 Apr; 24(2):180-8. PubMed ID: 26198438
[TBL] [Abstract][Full Text] [Related]
45. Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage.
Xie A; Aihara Y; Bouryi VA; Nikitina E; Jahromi BS; Zhang ZD; Takahashi M; Macdonald RL
J Cereb Blood Flow Metab; 2007 Oct; 27(10):1692-701. PubMed ID: 17392694
[TBL] [Abstract][Full Text] [Related]
46. Cortical blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage: three-dimensional N-isopropyl-p-[(123)I]iodoamphetamine single photon emission CT findings.
Ohkuma H; Suzuki S; Kudo K; Islam S; Kikkawa T
AJNR Am J Neuroradiol; 2003 Mar; 24(3):444-50. PubMed ID: 12637295
[TBL] [Abstract][Full Text] [Related]
47. Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review.
Thompson JC; Chalet FX; Manalastas EJ; Hawkins N; Sarri G; Talbot DA
Neurol Ther; 2022 Jun; 11(2):597-620. PubMed ID: 35441974
[TBL] [Abstract][Full Text] [Related]
48. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
[TBL] [Abstract][Full Text] [Related]
49. Distribution of delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhage and implications for regional neuromonitoring.
Miller CM; Palestrant D
Clin Neurol Neurosurg; 2012 Jul; 114(6):545-9. PubMed ID: 22176917
[TBL] [Abstract][Full Text] [Related]
50. Hyperoxemia and Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
Reynolds RA; Amin SN; Jonathan SV; Tang AR; Lan M; Wang C; Bastarache JA; Ware LB; Thompson RC
Neurocrit Care; 2021 Aug; 35(1):30-38. PubMed ID: 33150573
[TBL] [Abstract][Full Text] [Related]
51. Magnesium in subarachnoid haemorrhage: proven beneficial?
van den Bergh WM
Magnes Res; 2009 Sep; 22(3):121-6. PubMed ID: 19780398
[TBL] [Abstract][Full Text] [Related]
52. Prevention of symptomatic vasospasm after SAH by constant venous infusion of nimodipine.
Grotenhuis JA; Bettag W
Neurol Res; 1986 Dec; 8(4):243-9. PubMed ID: 2880316
[TBL] [Abstract][Full Text] [Related]
53. Coil embolization for intracranial aneurysms: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(1):1-114. PubMed ID: 23074479
[TBL] [Abstract][Full Text] [Related]
54. A double-blind clinical evaluation of the effect of Nizofenone (Y-9179) on delayed ischemic neurological deficits following aneurysmal rupture.
Saito I; Asano T; Ochiai C; Takakura K; Tamura A; Sano K
Neurol Res; 1983; 5(4):29-47. PubMed ID: 6149485
[TBL] [Abstract][Full Text] [Related]
55. Erythropoietin for the Treatment of Subarachnoid Hemorrhage: A Feasible Ingredient for a Successful Medical Recipe.
Grasso G; Tomasello G; Noto M; Alafaci C; Cappello F
Mol Med; 2016 Mar; 21(1):979-987. PubMed ID: 26581085
[TBL] [Abstract][Full Text] [Related]
56. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients?
Sarrafzadeh AS; Sakowitz OW; Kiening KL; Benndorf G; Lanksch WR; Unterberg AW
Crit Care Med; 2002 May; 30(5):1062-70. PubMed ID: 12006804
[TBL] [Abstract][Full Text] [Related]
57. The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study.
Muizelaar JP; Zwienenberg M; Rudisill NA; Hecht ST
J Neurosurg; 1999 Jul; 91(1):51-8. PubMed ID: 10389880
[TBL] [Abstract][Full Text] [Related]
58. Thick and Diffuse Subarachnoid Blood as a Treatment Effect Modifier of Clazosentan After Subarachnoid Hemorrhage.
Mayer SA; Aldrich EF; Bruder N; Hmissi A; Macdonald RL; Viarasilpa T; Marr A; Roux S; Higashida RT
Stroke; 2019 Oct; 50(10):2738-2744. PubMed ID: 31394993
[TBL] [Abstract][Full Text] [Related]
59. Intravenous magnesium therapy in adult patients with an aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.
Yarad EA; Hammond NE
Aust Crit Care; 2013 Aug; 26(3):105-17. PubMed ID: 23806874
[TBL] [Abstract][Full Text] [Related]
60. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
Haley EC; Kassell NF; Torner JC
J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
